Market Tracker

10/21 2:23pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

6.79
Data as of 2:07pm ET
 -0.03 / -0.44%
Today’s Change
5.40
Today|||52-Week Range
11.88
-8.12%
Year-to-Date
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close6.82
Today’s open6.86
Day’s range6.62 - 6.95
Volume47,280
Average volume (3 months)63,875
Market cap$295.9M
Dividend yield--
Data as of 2:07pm ET, 10/21/2014

Growth & Valuation

Earnings growth (last year)+76.89%
Earnings growth (this year)-106.46%
Earnings growth (next 5 years)--
Revenue growth (last year)+54.09%
P/E ratioNM
Price/Sales14.53
Price/Book3.05

Competitors

 Today’s
change
Today’s
% change
SVASinovac Biotech Ltd+0.01+0.19%
PRQRProQR Therapeutics N...-0.17-1.33%
NWBONorthwest Biotherape...+0.25+5.24%
ACRXAcelRx Pharmaceutica...-0.07-1.01%
Data as of 2:20pm ET, 10/21/2014

Financials

Next reporting dateNovember 12, 2014
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$19.6M
Annual profit (last year)-$18.7M
Net profit margin-95.40%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, CEO, CFO, Director &
CAO
Kleanthis G. Xanthopoulos
Chief Scientific Officer
Neil W. Gibson
Corporate headquarters
San Diego, California

Forecasts